In fact, the differentiation between primary and substance-induced MDD in dual pathology is a field of study to be explored, and a recent research has showed that platelet IRAS/nischarim (I1-Imidazoline receptor) could discriminate between primary MDD and cocaine-induced MDD in CUD patients [51]. This evidence concerns the gene NISCH and major depressive disorder.